A detailed history of Oxford Financial Group LTD transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Oxford Financial Group LTD holds 5,086 shares of BMY stock, worth $293,767. This represents 0.02% of its overall portfolio holdings.

Number of Shares
5,086
Previous 7,124 28.61%
Holding current value
$293,767
Previous $295,000 10.85%
% of portfolio
0.02%
Previous 0.02%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$39.66 - $51.75 $80,827 - $105,466
-2,038 Reduced 28.61%
5,086 $263,000
Q2 2024

Aug 13, 2024

BUY
$40.25 - $52.99 $7,406 - $9,750
184 Added 2.65%
7,124 $295,000
Q1 2024

May 13, 2024

SELL
$47.98 - $54.4 $31,282 - $35,468
-652 Reduced 8.59%
6,940 $376,000
Q4 2023

Feb 14, 2024

BUY
$48.48 - $57.85 $193 - $231
4 Added 0.05%
7,592 $389,000
Q3 2023

Nov 13, 2023

SELL
$57.89 - $64.73 $69,120 - $77,287
-1,194 Reduced 13.6%
7,588 $440,000
Q2 2023

Aug 10, 2023

BUY
$63.71 - $70.74 $47,272 - $52,489
742 Added 9.23%
8,782 $561,000
Q1 2023

May 12, 2023

BUY
$65.71 - $74.53 $45,865 - $52,021
698 Added 9.51%
8,040 $557,000
Q4 2022

Feb 14, 2023

BUY
$68.48 - $81.09 $20,407 - $24,164
298 Added 4.23%
7,342 $528,000
Q3 2022

Nov 02, 2022

SELL
$0.13 - $76.84 $270 - $159,904
-2,081 Reduced 22.81%
7,044 $501,000
Q2 2022

Aug 11, 2022

BUY
$72.62 - $79.98 $156,060 - $171,877
2,149 Added 30.81%
9,125 $703,000
Q1 2022

May 13, 2022

BUY
$61.48 - $73.72 $56,500 - $67,748
919 Added 15.17%
6,976 $509,000
Q4 2021

Feb 10, 2022

BUY
$53.63 - $62.52 $14,104 - $16,442
263 Added 4.54%
6,057 $378,000
Q3 2021

Nov 12, 2021

BUY
$59.17 - $69.31 $19,940 - $23,357
337 Added 6.18%
5,794 $343,000
Q1 2021

May 10, 2021

SELL
$59.34 - $66.74 $849,511 - $955,449
-14,316 Reduced 72.4%
5,457 $345,000
Q4 2020

Feb 10, 2021

BUY
$57.74 - $65.43 $25,867 - $29,312
448 Added 2.32%
19,773 $1.23 Million
Q3 2020

Nov 12, 2020

BUY
$57.43 - $63.64 $3,388 - $3,754
59 Added 0.31%
19,325 $1.17 Million
Q2 2020

Aug 05, 2020

SELL
$54.82 - $64.09 $8,277 - $9,677
-151 Reduced 0.78%
19,266 $1.13 Million
Q1 2020

May 12, 2020

BUY
$46.4 - $67.43 $900,948 - $1.31 Million
19,417 New
19,417 $1.08 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Oxford Financial Group LTD Portfolio

Follow Oxford Financial Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oxford Financial Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Oxford Financial Group LTD with notifications on news.